The incident unfolded on April 29, 2026, when a patient reported finding Citalopram—a different SSRI—inside a pack labeled for Sertraline. Both medications are commonly prescribed to manage depression and anxiety, which makes this mix-up particularly concerning.

Amarox Limited, the company responsible for the packaging, initiated the recall as a precautionary measure. They noted that the error occurred during the secondary packaging process, where blister strips were incorrectly placed into cartons.

Key facts about the recall:

• Over 81,872 packs of Sertraline were affected by this recall.
• The specific batch number involved is V2500425.
• Patients who mistakenly took Citalopram should seek medical advice immediately.

This situation underscores the importance of vigilance in pharmaceutical practices. Dr. Alison Cave from the Medicines and Healthcare products Regulatory Agency (MHRA) emphasized that patients need to verify their prescriptions carefully.

She stated, “If you have been prescribed Sertraline 100mg tablets and have received batch number V2500425, please check the carton contains the right medication.” This advice serves as a reminder that even minor errors can lead to significant health implications.

Moreover, Dr. Cave warned that patients who accidentally took Citalopram instead of Sertraline may experience heightened serotonergic side effects. These can include nausea, headache, sleep changes, and mild anxiety—effects that could complicate an already delicate mental health situation.

With over 16.7 million prescriptions for Sertraline issued in England in 2019 alone, this incident raises broader concerns about quality control in pharmaceutical manufacturing. How can we ensure that such errors do not happen again?

Сообщение Antidepressants Recall: A Significant Medication Error Uncovered появились сначала на Latest News UK.